BCL2 and cancer: Therapeutic strategies targeting Bcl-2 represent a promising prospect for treating many types of cancers [41]; increased expression levels of the proapoptotic Bcl-2 family proteins will promote the apoptosis of cancer cells, whereas increased expression levels of the antiapoptotic Bcl-2 family proteins will preserve cell survival [42].